IP Library Granted Patent US 8,628,791
Granted Patent B2
US 8,628,791 · App. 13/071,396 · Granted Jan 14, 2014

Method of forming an implantable knitted fabric comprising silk fibroin fibers

Inventors: Gregory H. Altman (Arlington, MA); Jingson Chen (Virginia Beach, VA); Rebecca L. Horan (Arlington, MA); David J. Horan (Westfield, MA)
Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,628,791
App. No.
13/071,396
Granted
Jan 14, 2014
Kind
B2
Abstract

Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.

Claims (23)

1. A method for forming an implantable knitted fabric comprising:

(a) aligning silk fibroin fibers in parallel or intertwined with other silk fibroin fibers to form a yarn,

(b) non-randomly organizing a plurality of the yarns to form the implantable knitted fabric, and

(c) before or after forming the yarn or fabric, substantially removing sericin from the silk fibroin fibers without substantially altering the native structure of fibroin in the fibers,

wherein the fibroin fibers having sericin substantially removed have not been dissolved and reconstituted.

2. The method of claim 1 , further comprising intertwining the parallel silk fibers before the sericin is extracted.

3. The method of claim 1 , further comprising intertwining the parallel silk fibers after the sericin is extracted.

4. The method of claim 1 , further comprising aligning multiple fibroin fibers into yarns, wherein each yarn comprises at least three parallel or intertwined fibers.

5. The method of claim 1 , wherein the fibroin fibers of each yarn are twisted about each other at 0 to 11.8 twists per cm.

6. The method of claim 1 , wherein multiple yarns are twisted about each other at 0 to 11.8 twists per cm.

7. The method of claim 1 , wherein sericin is extracted from no more than about 50 parallel or intertwined fibroin fibers.

8. The method of claim 1 , wherein the yarn is twisted at or below 30 twists per inch.

9. The method of claim 1 , further comprising associating a drug with the fabric.

10. The method of claim 1 , further comprising associating a cell-attachment factor with the fabric.

11. The method of claim 10 , further comprising associating arginine-glycine-aspartate (RGD) peptide with the fabric.

12. The method of claim 1 , further comprising treating the fabric with gas plasma.

13. The method of claim 1 , further comprising sterilizing the fabric.

14. A method for forming an implantable knitted fabric comprising:

(a) aligning silk fibroin fibers in parallel or intertwined with other silk fibroin fibers to form a yarn,

(b) non-randomly organizing a plurality of the yarns to form the implantable knitted fabric,

(c) before or after forming the yarn or fabric, substantially removing sericin from the silk fibroin fibers without substantially altering the native structure of fibroin in the fibers, and

(d) sterilizing the fabric,

wherein the fibroin fibers having sericin substantially removed have not been dissolved and reconstituted.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2016
From: SERICA TECHNOLOGIES, INC.
To: ALLERGAN, INC.
Reel/Frame 037594/0637 →
Continuity (4)
Division 10800134 · Mar 11, 2004
Continuation In Part 10008924 · Nov 16, 2001
Provisional Application 60453584 · Mar 11, 2003
Related Publication 20110167602A1 · Jul 14, 2011